The story has been corrected to reflect the correct amount of Guardant Health's financing round in January 2016.

NEW YORK (GenomeWeb) – Guardant Health today announced it has raised $360 million to finance a new goal to sequence the tumor DNA of more than 1 million cancer patients within five years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.